Lam Research Corporation $LRCX Stock Position Reduced by Allianz SE

Allianz SE lessened its stake in Lam Research Corporation (NASDAQ:LRCX) by 82.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,460 shares of the semiconductor company’s stock after selling 16,710 shares during the quarter. Allianz SE’s holdings in Lam Research were worth $337,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. ABN Amro Investment Solutions acquired a new position in shares of Lam Research in the second quarter worth $4,320,000. Smithfield Trust Co grew its stake in Lam Research by 2.9% in the second quarter. Smithfield Trust Co now owns 16,126 shares of the semiconductor company’s stock valued at $1,568,000 after purchasing an additional 462 shares in the last quarter. Cherokee Insurance Co acquired a new position in Lam Research in the 2nd quarter worth about $438,000. Candriam S.C.A. raised its stake in shares of Lam Research by 23.6% during the 2nd quarter. Candriam S.C.A. now owns 1,030,267 shares of the semiconductor company’s stock worth $100,290,000 after purchasing an additional 196,434 shares in the last quarter. Finally, Impax Asset Management Group plc purchased a new stake in shares of Lam Research during the 2nd quarter worth about $1,247,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Trading Down 5.0%

Shares of Lam Research stock opened at $153.32 on Friday. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $167.15. The company’s fifty day simple moving average is $139.84 and its 200-day simple moving average is $108.87. The company has a market cap of $192.57 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 1.68 and a beta of 1.87. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the firm earned $0.86 EPS. The business’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s payout ratio is currently 22.91%.

Insider Buying and Selling at Lam Research

In other news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the sale, the insider directly owned 56,786 shares in the company, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the transaction, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 62,528 shares of company stock valued at $8,880,448 in the last quarter. Corporate insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Wall Street Zen downgraded Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Dbs Bank boosted their target price on shares of Lam Research from $119.40 to $184.20 in a research report on Monday, October 27th. Erste Group Bank assumed coverage on shares of Lam Research in a report on Thursday, August 14th. They set a “buy” rating on the stock. Raymond James Financial lifted their price objective on shares of Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. Finally, Barclays set a $142.00 target price on shares of Lam Research and gave the stock an “equal weight” rating in a research report on Monday, October 20th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $149.04.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.